Olivier Épaulard

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020

Kostas Danis, Olivier Épaulard, Thomas Bénet et al. · Clinical Infectious Diseases · 2020 · 263 citations · Full text

Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort

Jade Ghosn, Lionel Piroth, Olivier Épaulard et al. · Clinical Microbiology and Infection · 2021 · 193 citations · Full text

Large Prospective Cohort, Virus Epidemiology, Persistent Covid-19 Symptoms +7

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 153 citations

Community-acquired Pneumonia, Critical Care Medicine, Antibiotics +7

Vaccine Education of Medical Students: A Nationwide Cross-sectional Survey

Solen Kernéis, Caroline Jacquet, Aurélie Bannay et al. · American Journal of Preventive Medicine · 2017 · 127 citations

Vaccination, Preventive Medicine, Vaccine Education +3